Last reviewed · How we verify
HGP0904 and HGP1201 co-administraion — Competitive Intelligence Brief
phase 1
Small molecule
Live · refreshed every 30 min
Target snapshot
HGP0904 and HGP1201 co-administraion (HGP0904 and HGP1201 co-administraion) — Hanmi Pharmaceutical Company Limited.
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| HGP0904 and HGP1201 co-administraion TARGET | HGP0904 and HGP1201 co-administraion | Hanmi Pharmaceutical Company Limited | phase 1 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- HGP0904 and HGP1201 co-administraion CI watch — RSS
- HGP0904 and HGP1201 co-administraion CI watch — Atom
- HGP0904 and HGP1201 co-administraion CI watch — JSON
- HGP0904 and HGP1201 co-administraion alone — RSS
Cite this brief
Drug Landscape (2026). HGP0904 and HGP1201 co-administraion — Competitive Intelligence Brief. https://druglandscape.com/ci/hgp0904-and-hgp1201-co-administraion. Accessed 2026-05-18.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab